Abstract:Summary Background Observational studies have associated obesity with an increased risk of multiple sclerosis (MS). However, the role of genetic factors in their comorbidity remains largely unknown. Our study aimed to investigate the shared genetic architecture underlying obesity and MS. Methods By leveraging data from genome-wide association studies, we investigated the genetic correlation of body mass index (BMI) and MS by linkage disequilibrium score regression and genetic covariance analyser. The casualty was identified by bidirectional Mendelian randomisation. Linkage disequilibrium score regression in specifically expressed genes and multimarker analysis of GenoMic annotation was utilised to explore single-nucleotide polymorphism (SNP) enrichment at the tissue and cell-type levels. Shared risk SNPs were derived using cross-trait meta-analyses and Heritability Estimation from Summary Statistics. We explored the potential functional genes using summary-data-based Mendelian randomization (SMR). The expression profiles of the risk gene in tissues were further examined. Findings We found a significantly positive genetic correlation between BMI and MS, and the causal association of BMI with MS was supported (β = 0.22, P = 8.03E-05). Cross-trait analysis yielded 39 shared risk SNPs, and the risk gene GGNBP2 was consistently identified in SMR. We observed tissue-specific level SNP heritability enrichment for BMI mainly in brain tissues for MS in immune-related tissues, and cell-type-specific level SNP heritability enrichment in 12 different immune cell types in brain, spleen, lung, and whole blood. The expressions of GGNBP2 were significantly altered in the tissues of patients with obesity or MS compared to those of control subjects. Interpretation Our study indicates the genetic correlation and shared risk genes between obesity and MS. These findings provide insights into the potential mechanisms behind their comorbidity and the future development of therapeutics. Funding This work was funded by the National Natural Science Foundation of China ( 82171698 , 82170561 , 81300279 , and 81741067 ), the Program for High-level Foreign Expert Introduction of China (G2022030047L), the Natural Science Foundation for Distinguished Young Scholars of Guangdong Province ( 2021B1515020003 ), Natural Science Foundation of Guangdong Province ( 2022A1515012081 ), the Foreign Distinguished Teacher Program of Guangdong Science and Technology Department (KD0120220129), the Climbing Programme of Introduced Talents and High-level Hospital Construction Project of Guangdong Provincial People's Hospital ( DFJH201803 , KJ012019099 , KJ012021143 , and KY012021183 ), and in part by VA Clinical Merit and ASGE clinical research funds (FWL).

Utilising multi-large omics data to elucidate biological mechanisms within multiple sclerosis genetic susceptibly loci

Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis

Multi-omics Analysis to Identify Susceptibility Genes for Colorectal Cancer.

Functional relevance for multiple sclerosis-associated genetic variants

Genome-wide identification and analysis of the eQTL lncRNAs in multiple sclerosis based on RNA-seq data

Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study

Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways

GWAS highlights the neuronal contribution to multiple sclerosis susceptibility

Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis

Combining gene expression microarrays and Mendelian randomization: exploring key immune-related genes in multiple sclerosis

Gene-Based Tests of a Genome-Wide Association Study Dataset Highlight Novel Multiple Sclerosis Risk Genes

Multi-omics integration prioritizes potential drug targets for multiple sclerosis

Brain proteome‐wide association study linking‐genes in multiple sclerosis pathogenesis

Integrating Genetic and Proteomic Data to Elucidate the Association Between Immune System and Blood-Brain Barrier Dysfunction with Multiple Sclerosis Risk and Severity

Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis

Dissecting shared genetic architecture between obesity and multiple sclerosis

Integrated analyses of single-cell transcriptome and Mendelian randomization reveal the protective role of FCRL3 in multiple sclerosis

Examination of the shared genetic architecture between multiple sclerosis and systemic lupus erythematosus facilitates discovery of novel lupus risk loci

Multi-omics Mendelian randomisation using expression, protein and splicing quantitative trait loci to identify novel drug targets associated with risk of gliomagenesis

Identification of Schizophrenia-Associated Loci by Combining DNA Methylation and Gene Expression Data from Whole Blood

Locus for severity implicates CNS resilience in progression of multiple sclerosis